Hrt Financial LP Oramed Pharmaceuticals Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.71 - $2.57 $19,092 - $28,694	11,165 New	11,165 $25,000
Q1 2023 May 12, 2023	BUY	$1.93 - $13.1 $86,917 - $589,958	45,035 New	45,035 $98,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $525,781 - $891,710	-64,198 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $833,290 - $1.91 Million	64,198 New	64,198 $916,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.1M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.